0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z
**IMPORTANT**
The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
European League of Stuttering Associations
a/k/a: ELSA
Address
31 Grosvenor Road
Jesmond
Newcastle-Upon-Tyne, NE2 2RL
United Kingdom
Phone
441-912-818003
Fax
441-912-818003
800 Number
--
TDD
--
Email Address
elsa.europe@totalise.co.uk
Website
The European League of Stuttering Associations (ELSA) is an international, non-profit organization dedicated to facilitating the exchange of information among organizations, representing the interests of Europeans who stutter. Stuttering is a speech abnormality characterized by repeated hesitation or delay in enunciating words, abnormally prolonged pauses, and repetition of parts of words or entire words. ELSA promotes the exchange of information among European national organizations by conducting and compiling surveys; maintaining a library of the European associations' educational materials; publishing a regular newsletter; and conducting seminars that bring together organizational board members, other interested delegates, and professionals in the field. ELSA also provides advocacy for the interests and needs of affected individuals before the European Council and the European Union.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.
